With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Health financing and payment, results-based financing, social protection, conditional cash transfer programs, noncommunicable disease, maternal and child health
Amanda Glassman is chief operating officer and senior fellow at the Center for Global Development and also serves as secretary of the board. Her research focuses on priority-setting, resource allocation and value for money in global health, as well as data for development. Prior to her current position, she served as director for global health policy at the Center from 2010 to 2016, and has more than 25 years of experience working on health and social protection policy and programs in Latin America and elsewhere in the developing world.
Prior to joining CGD, Glassman was principal technical lead for health at the Inter-American Development Bank, where she led policy dialogue with member countries, designed the results-based grant program Salud Mesoamerica 2015 and served as team leader for conditional cash transfer programs such as Mexico’s Oportunidades and Colombia’s Familias en Accion. From 2005-2007, Glassman was deputy director of the Global Health Financing Initiative at Brookings and carried out policy research on aid effectiveness and domestic financing issues in the health sector in low-income countries. Before joining the Brookings Institution, Glassman designed, supervised and evaluated health and social protection loans at the Inter-American Development Bank and worked as a Population Reference Bureau Fellow at the US Agency for International Development. Glassman holds a MSc from the Harvard School of Public Health and a BA from Brown University, has published on a wide range of health and social protection finance and policy topics, and is editor and coauthor of the books Millions Saved: New Cases of Proven Success in Global Health (Center for Global Development 2016), From Few to Many: A Decade of Health Insurance Expansion in Colombia (IDB and Brookings 2010), and The Health of Women in Latin America and the Caribbean (World Bank 2001).
One of the few things donors agreed on at the High Level Forum on Aid Effectiveness in Busan was the need for increased transparency: better aid data is needed to help donors channel their aid more effectively and recipient countries hold their donors accountable. Yet despite the shared commitment, data on aid flows remains incomplete, complicated and fragmented, particularly at the sector level.
The President’s budget request for 2013 is out: total money spent on GHI is reduced by 3.5% and PEPFAR’s budget shrinks by 10.8%. While both figures may be alarming, there is a bright spot: contributions to the Global Fund for AIDS, TB and Malaria go up by 27% to $1.65 billion. In addition to the Global Fund, GAVI, IDA, Asian Development Fund and the African Development Fund are all among agencies that are getting increases on their funding; notably, GAVI by 11.5%.
Which donor provides the "best" health aid, and why is it a relevant question? We attempted to answer these questions by adapting the Quality of Official Development Assistance (QuODA) methodology to health aid. To be honest, one working paper later, we still do not have a definite answer to either question.